Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Directorate Change

24 Feb 2025 09:23

RNS Number : 1950Y
Jardine Matheson Hldgs Ltd
24 February 2025
Β 

JARDINE MATHESON HOLDINGS LIMITED

Β 

Appointment of Independent Non-Executive Director

Β 

Jardine Matheson Holdings Limited (the 'Company') announces that Ming Lu has been appointed as a Non-executive Director of the Company with effect from 24 February 2025.

Β 

Ming is a Senior Advisory Partner of KKR, based in Hong Kong. He joined KKR in 2006 and has held a series of senior roles with the firm, including Executive Chairman, Asia Pacific at KKR Asia Limited and a Partner of Kohlberg Kravis Roberts & Co. L.P.

Β 

Ming has played a significant role over many years in private equity investments across Asia Pacific and, since 2018, has been playing a leadership role in KKR Asia's growth and expansion, including serving as a member of the Asian Infrastructure Investment Committee and Asian Real Estate Investment Committee.

Β 

Ming was previously a Partner at CCMP Capital Asia (formerly J.P. Morgan Partners Asia), where he was responsible for investments in the automotive, consumer and industrial sectors in Korea, China, Japan, Australia and Southeast Asia.

Β 

Prior to joining JPMP Asia in 1999, Ming was President of Asia Pacific at Lucas Varity, a leading global automotive component supplier. He also worked for Kraft Foods International Inc. and CITIC, the largest direct investment firm in China.

Β 

Ben Keswick, Executive Chairman, said:

Β 

"I am delighted to welcome Ming to the Board and to the Jardines group. As a global investment expert, I believe that Ming will make an important contribution to the future growth of the Group. We look forward to benefitting from his counsel and advice, based on his unrivalled experience of leading and building a highly-respected and successful business and his deep knowledge of, and strong reputation in, Asia."

Β 

In connection with the above appointment, the Company advises that Ming Lu has held directorships in the following listed companies in the past five years:

Β 

Prudential plc

Independent Non-executive Director

May 2021 - present

Jones Lang Lasalle

Independent Non-executive Director

May 2009 - May 2021

Β 

Β 

Jonathan Lloyd, Jardine Matheson Limitedfor and on behalf of Jardine Matheson Holdings Limited 24 February 2025 www.jardines.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAPPUGPPUPAUBC
Date   Source Headline
29th May 202610:53 amRNSTotal Voting Rights
29th May 202610:47 amRNSDirector/PDMR Shareholding
28th May 202611:31 amRNSTransaction in Own Shares
27th May 202610:27 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSAcquisition of I-MED Radiology Network
22nd May 202610:23 amRNSInterim Management Statement
19th May 202612:22 pmRNSINTERIM MANAGEMENT STATEMENT
18th May 202612:57 pmRNSNotification of Issuance of Equity Securities
18th May 202612:30 pmRNSDirector/PDMR Shareholding
7th May 20261:01 pmRNSAdditional Listing
7th May 202612:49 pmRNSDirector/PDMR Shareholding
7th May 202612:44 pmRNSResult of AGM
5th May 202610:54 amRNSTransaction in Own Shares
5th May 202610:19 amRNSTransaction in Own Shares
30th Apr 202611:51 amRNSTotal Voting Rights
30th Apr 202611:50 amRNSTransaction in Own Shares
30th Apr 202610:47 amRNSJC&C Interim Management Statement
29th Apr 202612:28 pmRNSPT Astra 2026 First Quarter Financial Statements
29th Apr 202611:59 amRNSTransaction in Own Shares
29th Apr 202610:48 amRNSDividend
28th Apr 202611:35 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202611:26 amRNSDividend
22nd Apr 202611:12 amRNSTransaction in Own Shares
21st Apr 202610:57 amRNSTransaction in Own Shares
20th Apr 202611:01 amRNSTransaction in Own Shares
14th Apr 202611:31 amRNSTransaction in Own Shares
13th Apr 202611:27 amRNSTransaction in Own Shares
10th Apr 202611:23 amRNSTransaction in Own Shares
8th Apr 202611:53 amRNSTransaction in Own Shares
8th Apr 202610:25 amRNSAnnual Financial Report
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20268:02 amRNSTransaction in Own Shares
1st Apr 202611:17 amRNSTransaction in Own Shares
1st Apr 202610:34 amRNSCirc re. Scrip Dividend Scheme
1st Apr 202610:21 amRNSDirector/PDMR Shareholding
31st Mar 202611:59 amRNSDirector/PDMR Shareholding
31st Mar 202611:53 amRNSTotal Voting Rights
31st Mar 202611:46 amRNSTransaction in Own Shares
30th Mar 202611:08 amRNSTransaction in Own Shares
27th Mar 20269:43 amRNSDirector/PDMR Shareholding
25th Mar 202611:05 amRNSDirector/PDMR Shareholding
25th Mar 202610:31 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:07 amRNSTransaction in Own Shares
20th Mar 20269:26 amRNSDirector/PDMR Shareholding
17th Mar 20269:55 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
13th Mar 20269:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.